Trial Profile
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study—STAT Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2023
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Proof of concept; Therapeutic Use
- Acronyms STAT Study
- 22 Feb 2023 Results presented in the Mannkind pharma media release.
- 22 Feb 2023 According to Mannkind media release, the oral presentation describing meal challenge results will be presented at the 16th International Conference on Advanced Technologies & Treatment for Diabetes (ATTD) in Berlin from February 22nd-25th.
- 03 Jun 2021 According to a MannKind Corporation media release, a post hoc analysis of this trial will be presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021) to be held virtually.